keyword
https://read.qxmd.com/read/38702989/gedunin-modulates-cellular-growth-and-apoptosis-in-glioblastoma-cell-lines
#41
JOURNAL ARTICLE
Michael Stouffer, Elizabeth Wandling, Lindsay Dickson, Stacy Lin, Huanyun Duan, Erika Powe, Denise Jean-Louis, Amit K Tiwari, Samson Amos
BACKGROUND: Glioblastomas are characterized by aggressive behavior. Surgery, radiotherapy, and alkylating agents, including temozolomide are the most common treatment options for glioblastoma. Often, conventional therapies fail to treat these tumors since they develop drug resistance. There is a need for newer agents to combat this deadly tumor. Natural products such as gedunin have shown efficacy in several human diseases. A comprehensive study of gedunin, an heat shock protein (HSP)90 inhibitor, has not been thoroughly investigated in glioblastoma cell lines with different genetic modifications...
May 2024: Cancer reports
https://read.qxmd.com/read/38700808/retrospective-assessment-of-translational-pharmacokinetic-pharmacodynamic-modeling-performance-a-case-study-with-apitolisib-a-dual-pi3k-mtor-inhibitor
#42
JOURNAL ARTICLE
Anita Moein, Jin Y Jin, Matthew R Wright, Bruno Alicke, Harvey Wong
BACKGROUND AND OBJECTIVES: Despite significant progress in biomedical research, the rate of success in oncology drug development remains inferior to that of other therapeutic fields. Mechanistic models provide comprehensive understanding of the therapeutic effects of drugs, which is crucial for designing effective clinical trials. This study was performed to acquire a better understanding of PI3K-AKT-TOR pathway modulation and preclinical to clinical translational bridging for a specific compound, apitolisib (PI3K/mTOR inhibitor), by developing integrated mechanistic models...
May 3, 2024: Drugs in R&D
https://read.qxmd.com/read/38700244/the-activity-of-pyrazolo-4-3-e-1-2-4-triazine-and-pyrazolo-4-3-e-tetrazolo-1-5-b-1-2-4-triazine-sulphonamide-derivatives-in-monolayer-and-spheroid-breast-cancer-cell-cultures
#43
JOURNAL ARTICLE
Anna Szymanowska, Dominika Radomska, Robert Czarnomysy, Mariusz Mojzych, Katarzyna Kotwica-Mojzych, Krzysztof Bielawski, Anna Bielawska
In the last decade, an increasing interest in compounds containing pyrazolo[4,3- e ][1,2,4]triazine moiety is observed. Therefore, the aim of the research was to synthesise a novel sulphonyl pyrazolo[4,3- e ][1,2,4]triazines ( 2a , 2b ) and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives ( 3a , 3b ) to assess their anticancer activity. The MTT assay showed that 2a , 2b , 3a , 3b have stronger cytotoxic activity than cisplatin in both breast cancer cells (MCF-7 and MDA-MB-231) and exhibited weaker effect on normal breast cells (MCF-10A)...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38693123/primary-prophylaxis-with-mtor-inhibitor-enhances-t%C3%A2-cell-effector-function-and-prevents-heart-transplant-rejection-during-talimogene-laherparepvec-therapy-of-squamous-cell-carcinoma
#44
JOURNAL ARTICLE
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Giuseppe Pantaleo, Michel Obeid
The application of mammalian target of rapamycin inhibition (mTORi) as primary prophylactic therapy to optimize T cell effector function while preserving allograft tolerance remains challenging. Here, we present a comprehensive two-step therapeutic approach in a male patient with metastatic cutaneous squamous cell carcinoma and heart transplantation followed with concomitant longitudinal analysis of systemic immunologic changes. In the first step, calcineurin inhibitor/ mycophenolic acid is replaced by the mTORi everolimus to achieve an improved effector T cell status with increased cytotoxic activity (perforin, granzyme), enhanced proliferation (Ki67) and upregulated activation markers (CD38, CD69)...
April 30, 2024: Nature Communications
https://read.qxmd.com/read/38692059/ziprasidone-triggers-inflammasome-signaling-via-pi3k-akt-mtor-pathway-to-promote-atrial-fibrillation
#45
JOURNAL ARTICLE
Ming-Kun Lu, Yen-Nien Huo, Buh-Yuan Tai, Chih-Yuan Lin, Hsiang-Yu Yang, Chien-Sung Tsai
BACKGROUND: Second-generation antipsychotics increase the risk of atrial fibrillation. This study explores whether the atypical antipsychotic ziprasidone triggers inflammasome signaling, leading to atrial arrhythmia. METHODS: Electromechanical and pharmacological assessments were conducted on the rabbit left atria (LA). The patch-clamp technique was used to measure ionic channel currents in single cardiomyocytes. Detection of cytosolic reactive oxygen species production was performed in atrial cardiomyocytes...
April 30, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38691879/bpa-promotes-lung-fibrosis-in-mice-by-regulating-autophagy-dependent-ferroptosis-in-alveolar-epithelial-cells
#46
JOURNAL ARTICLE
Ni Liang, Wenyi Song, Jing Li
BACKGROUND: Bisphenol A (BPA) is an industrial chemical that is commonly found in daily consumer products. BPA is reportedly associated with lung diseases. However, the impact of BPA on pulmonary fibrosis (PF) and its possible mechanisms of action both remain unclear. METHODS: A PF mouse model was induced by bleomycin (BLM). Mouse lung fibroblasts (MLG 2908) and mouse alveolar epithelial cells (MLE-12) were treated with BPA to establish a PF cell model. Tissue staining, CCK-8 assays, western blot experiments and relevant indicator kits were used to detect and evaluate the effect of BPA on PF...
April 30, 2024: Ecotoxicology and Environmental Safety
https://read.qxmd.com/read/38691334/pmaip1-regulates-autophagy-in-osteoblasts-via-the-ampk-mtor-pathway-in-osteoporosis
#47
JOURNAL ARTICLE
Yijie Gao, Anquan Huang, Yantao Zhao, Yunxia Du
Osteoporosis (OP) is a highly prevalent disorder characterized by low bone mass that severely reduces patient quality of life. Although numerous treatments for OP have been introduced in clinic, many have side effects and high costs. Therefore, there is still an unmet need for optimal solutions. Here, raw signal analysis was used to identify potential high-risk factors for OP, and the biological functions and possible mechanisms of action (MOAs) of these factors were explored via gene set enrichment analysis (GSEA)...
April 30, 2024: Human Cell
https://read.qxmd.com/read/38690706/the-pi3k-signaling-pathway-from-normal-lymphopoiesis-to-lymphoid-malignancies
#48
REVIEW
Bahareh Kashani, Zahra Zandi, Atieh Pourbagheri-Sigaroodi, Amir-Mohammad Yousefi, Seyed H Ghaffari, Davood Bashash
INTRODUCTION: As a vital mechanism of survival, lymphopoiesis requires the collaboration of different signaling molecules to orchestrate each step of cell development and maturation. The PI3K pathway is considerably involved in the maturation of lymphatic cells and therefore, its dysregulation can immensely affect human well-being and cause some of the most prevalent malignancies. As a result, studies that investigate this pathway could pave the way for a better understanding of the lymphopoiesis mechanisms, the undesired changes that lead to cancer progression, and how to design drugs to solve this issue...
May 8, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38690514/unveiling-the-role-of-hypoxia-inducible-factor-2alpha-in-osteoporosis-implications-for-bone-health
#49
JOURNAL ARTICLE
Ling-Ling Wang, Zhan-Jin Lu, Shun-Kui Luo, Yun Li, Zhe Yang, Hong-Yun Lu
BACKGROUND: Osteoporosis (OP) has become a major public health problem worldwide. Most OP treatments are based on the inhibition of bone resorption, and it is necessary to identify additional treatments aimed at enhancing osteogenesis. In the bone marrow (BM) niche, bone mesenchymal stem cells (BMSCs) are exposed to a hypoxic environment. Recently, a few studies have demonstrated that hypoxia-inducible factor 2alpha (HIF-2α) is involved in BMSC osteogenic differentiation, but the molecular mechanism involved has not been determined...
April 26, 2024: World Journal of Stem Cells
https://read.qxmd.com/read/38689278/arginine-and-its-metabolites-stimulate-proliferation-differentiation-and-physiological-function-of-porcine-trophoblast-cells-through-%C3%AE-catenin-and-mtor-pathways
#50
JOURNAL ARTICLE
Shuai Li, Xiangyang Ye, Xiaolu Wen, Xuefen Yang, Li Wang, Kaiguo Gao, Hao Xiao, Zongyong Jiang
Arginine, which is metabolized into ornithine, proline, and nitric oxide, plays an important role in embryonic development. The present study was conducted to investigate the molecular mechanism of arginine in proliferation, differentiation, and physiological function of porcine trophoblast cells (pTr2) through metabolic pathways. The results showed that arginine significantly increased cell viability (P < 0.05). The addition of arginine had a quadratic tendency to increase the content of progesterone (P = 0...
April 30, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38685691/hydrogen-sulfide-protects-the-endometrium-in-a-rat-model-of-type-1-diabetes-via-modulation-of-ppar%C3%AE-mtor-and-nrf-2-nf-%C3%AE%C2%BAb-pathways
#51
REVIEW
Heba A Abdel-Hamid, Heba Marey, Manar Fouli Gaber Ibrahim
Diabetes is one of the leading causes of endometrial diseases in women. No study has addressed the influence of hydrogen sulphide (H2 S) donors on endometrial injury on top of type 1 diabetes. This research was conducted to study either the effect of sodium hydrosulphide (NaHS), the H2 S donor, or DL-propargylglycine (PAG), the inhibitor of endogenous H2 S production, on the endometrium of diabetic rats. A total of 40 female Wistar rats were separated into control group, diabetic group, diabetic group treated with NaHS and diabetic group treated with PAG...
April 29, 2024: Archives of Physiology and Biochemistry
https://read.qxmd.com/read/38682738/analyses-of-tumor-microenvironment-in-patients-with-advanced-renal-cell-carcinoma-receiving-immunotherapy-meet-uro-18-study
#52
JOURNAL ARTICLE
Fabio Catalano, Matteo Brunelli, Alessio Signori, Pasquale Rescigno, Sebastiano Buti, Luca Galli, Massimiliano Spada, Cristina Masini, Francesca Galuppini, Valerio Gaetano Vellone, Gabriele Gaggero, Marco Maruzzo, Sara Merler, Francesca Vignani, Alessia Cavo, Davide Bimbatti, Michele Milella, Angelo Paolo Dei Tos, Marta Sbaraglia, Veronica Murianni, Alessandra Damassi, Malvina Cremante, Michele Maffezzoli, Miguel Angel Llaja Obispo, Giuseppe Luigi Banna, Giuseppe Fornarini, Sara Elena Rebuzzi
Introduction: The Meet-URO 18 study is a multicentric study of patients with metastatic renal cell carcinoma receiving nivolumab in the second-line and beyond, categorized as responders (progression-free survival ≥ 12 months) and non-responders (progression-free survival < 3 months). Areas covered: The current study includes extensive immunohistochemical analysis of T-lineage markers (CD3, CD4, CD8, CD8/CD4 ratio), macrophages (CD68), ph-mTOR, CD15 and CD56 expression on tumor cells, and PD-L1 expression, on an increased sample size including 161 tumor samples (113 patients) compared with preliminary presented data...
April 29, 2024: Future Oncology
https://read.qxmd.com/read/38677763/cx-4945-silmitasertib-induces-cell-death-by-impairing-lysosomal-utilization-in-kras-mutant-cholangiocarcinoma-cell-lines
#53
JOURNAL ARTICLE
DA Sol Lee, Min Woo Han, Yonghyun Kang, Chorong Kim, Seonmin Lee, Kyu-Pyo Kim, Changhoon Yoo
BACKGROUND/AIM: Macropinocytosis is a non-selective form of endocytosis that facilitates the uptake of extracellular substances, such as nutrients and macromolecules, into the cells. In KRAS-driven cancers, including pancreatic ductal adenocarcinoma, macropinocytosis and subsequent lysosomal utilization are known to be enhanced to overcome metabolic stress. In this study, we investigated the role of Casein Kinase 2 (CK2) inhibition in macropinocytosis and subsequent metabolic processes in KRAS mutant cholangiocarcinoma (CCA) cell lines...
May 2024: Anticancer Research
https://read.qxmd.com/read/38676476/impact-of-combination-therapy-with-chemical-drugs-and-megavoltage-x-ray-exposure-on-breast-cancer-stem-cells-viability-and-proliferation-of-mcf-7-and-mda-mb-231-cell-lines
#54
JOURNAL ARTICLE
Fatemeh Banisharif Dehkordi, Mahdi Ghatrehsamani, Maryam Abdolvand, Amin Soltani, Seyed Hossein Masoumi
BACKGROUND: Breast Cancer (BC) is a serious malignancy among women. However, chemotherapy is an important tool for cancer treatments, but the long-term use of chemotherapy drugs may lead to drug resistance and tumor recurrence. Since Breast Cancer Stem Cells (BCSCs) can be the main factor to induce BC treatment resistance and recurrence, investigation of BCSCs signaling pathways can be an effective modality to enhance cancer treatment efficiency. OBJECTIVE: In this study, the effect of metformin, SB203580, and takinib alone or in combination with radiotherapy on MCF-7 and MDA-MB-231 breast cancer cell lines was evaluated...
April 25, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38674231/genomic-profiling-and-molecular-characterisation-of-metastatic-urothelial-carcinoma
#55
REVIEW
Gaetano Pezzicoli, Federica Ciciriello, Vittoria Musci, Silvia Minei, Antonello Biasi, Anna Ragno, Paola Cafforio, Mimma Rizzo
The clinical management of metastatic urothelial carcinoma (mUC) is undergoing a major paradigm shift; the integration of immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) into the mUC therapeutic strategy has succeeded in improving platinum-based chemotherapy outcomes. Given the expanding therapeutic armamentarium, it is crucial to identify efficacy-predictive biomarkers that can guide an individual patient's therapeutic strategy. We reviewed the literature data on mUC genomic alterations of clinical interest, discussing their prognostic and predictive role...
March 31, 2024: Medicina
https://read.qxmd.com/read/38672607/dichloroacetate-and-quercetin-prevent-cell-proliferation-induce-cell-death-and-slow-tumor-growth-in-a-mouse-model-of-hpv-positive-head-and-neck-cancer
#56
JOURNAL ARTICLE
Yongxian Zhuang, Joseph D Coppock, Allison B Haugrud, John H Lee, Shanta M Messerli, W Keith Miskimins
Elevated glucose uptake and production of lactate are common features of cancer cells. Among many tumor-promoting effects, lactate inhibits immune responses and is positively correlated with radioresistance. Dichloroacetate (DCA) is an inhibitor of pyruvate dehydrogenase kinase that decreases lactate production. Quercetin is a flavonoid compound found in fruits and vegetables that inhibits glucose uptake and lactate export. We investigated the potential role and mechanisms of DCA, quercetin, and their combination, in the treatment of HPV-positive head and neck squamous cell carcinoma, an antigenic cancer subtype in need of efficacious adjuvant therapies...
April 17, 2024: Cancers
https://read.qxmd.com/read/38672538/a-phase-ib-expansion-cohort-evaluating-aurora-a-kinase-inhibitor-alisertib-and-dual-torc1-2-inhibitor-sapanisertib-in-patients-with-advanced-solid-tumors
#57
JOURNAL ARTICLE
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Alexis D Leal, Christopher H Lieu, Cindy L O'Bryant, Stephen G Smoots, Evan D Dus, Kimberly R Jordan, Natalie J Serkova, Todd M Pitts, Jennifer R Diamond
BACKGROUND: This study further evaluated the safety and efficacy of the combination of alisertib and sapanisertib in an expansion cohort of patients, including a subset of patients with refractory pancreatic adenocarcinoma, with further evaluation of the pharmacodynamic characteristics of combination therapy. METHODS: Twenty patients with refractory solid tumors and 11 patients with pancreatic adenocarcinoma were treated at the recommended phase 2 dose of alisertib and sapanisertib...
April 10, 2024: Cancers
https://read.qxmd.com/read/38672125/immunolocalization-of-matrix-metalloproteinases-2-and-9-and-their-inhibitors-in-the-hearts-of-rats-treated-with-immunosuppressive-drugs-an-artificial-intelligence-based-digital-analysis
#58
JOURNAL ARTICLE
Aleksandra Wilk, Małgorzata Król, Kajetan Kiełbowski, Estera Bakinowska, Kamila Szumilas, Anna Surówka, Karolina Kędzierska-Kapuza
BACKGROUND: Immunosuppressive agents represent a broad group of drugs, such as calcineurin inhibitors, mTOR inhibitors, and glucocorticosteroids, among others. These drugs are widely used in a number of conditions, but lifelong therapy is crucial in the case of organ recipients to prevent rejection. To further increase the safety and efficacy of these agents, their off-target mechanisms of action, as well as processes underlying the pathogenesis of adverse effects, need to be thoroughly investigated...
March 30, 2024: Biomedicines
https://read.qxmd.com/read/38671459/sf3b3-regulated-mtor-alternative-splicing-promotes-colorectal-cancer-progression-and-metastasis
#59
JOURNAL ARTICLE
Tong Xu, Xichuan Li, Wennan Zhao, Xue Wang, Leixin Jin, Zhiqiang Feng, Huixiang Li, Mingzhe Zhang, Yiqing Tian, Ge Hu, Yuan Yue, Xintong Dai, Changliang Shan, Weihua Zhang, Chunze Zhang, Youcai Zhang
BACKGROUND: Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of U2 small nuclear ribonucleoproteins which are crucial for early stages of spliceosome assembly. The role of SF3B3 in CRC remains unknown. METHODS: SF3B3 expression in human CRCs was analyzed using publicly available CRC datasets, immunohistochemistry, qRT-PCR, and western blot. RNA-seq, RNA immunoprecipitation, and lipidomics were performed in SF3B3 knockdown or overexpressing CRC cell lines...
April 26, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38670450/tym-3-98-a-novel-selective-inhibitor-of-pi3k%C3%AE-demonstrates-promising-preclinical-antitumor-activity-in-b-cell-lymphomas
#60
JOURNAL ARTICLE
Si-Yue Lou, Fan-Li Zheng, Yong-Mei Tang, Ya-Nan Zheng, Jun Lu, Hai An, En-Jun Zhang, Sun-Liang Cui, Hua-Jun Zhao
AIMS: PI3Kδ is expressed predominately in leukocytes and is commonly found to be aberrantly activated in human B-cell lymphomas. Although PI3Kδ has been intensively targeted for discovering anti-lymphoma drugs, the application of currently approved PI3Kδ inhibitors has been limited due to unwanted systemic toxicities, thus warranting the development of novel PI3Kδ inhibitors with new scaffolds. MAIN METHODS: We designed TYM-3-98, an indazole derivative, and evaluated its selectivity for all four PI3K isoforms, as well as its efficacy against various B-cell lymphomas both in vitro and in vivo...
April 24, 2024: Life Sciences
keyword
keyword
119453
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.